Ivermectin vs Merck’s New Early Treatment Drug
By Frontline Covid-19 Critical Care Alliance
Newsmax’s Host Eric Bolling interviews Dr. Pierre Kory about Ivermectin and Merck’s new drug.
Donate to the Front Line Covid-19 Critical Care Alliance, Inc
To educate medical professionals and the public in safe and effective ways to prevent and treat COVID-19.